Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Commercial food additive, antioxidant.
Fatty acid metabolite of chlorophyll; RXR and P...
Endogenous antimicrobial peptide, binds bacteri...
γ-Secretase inhibitor.
Methimazole prodrug; thyroid peroxidase inhibit...
Synthesis impurity
Adenosine analog
Triterpenoid found in Vigna angularis and Trigo...
Endogenous tachykinin peptide, involved in infl...
Ras inhibitor.
FGFR inhibitor.
ITC, used as chiral agent.
p53 inhibitor
Semi-synthetic vinca alkaloid found in Catharan...
Flavonoid found in Scutellaria; CDK9 inhibitor....
Synthetic peptide derived from HIV-1; viral fus...
NSAID; COX-1/2 inhibitor.
AKT inhibitor, potential ROCK, p70S6K, PKA, MKK...
Cannabinoid receptor 2 selective agonist.
Atazanavir metabolite; HIV protease inhibitor.<...